Oncology & molecular teams
Bring the case, the alteration, and the clinical question into focus.
OncoSkepsis / Precision oncology
Clarity for
complex cases.
From scattered research to traceable evidence, ready for the people making the decisions.
Cited.
A source behind each statement.
Graded.
Evidence with its limitations in view.
Human-signed.
Your team has the final word.
More information.
Still unanswered questions.
A rare alteration. Conflicting findings. A case that does not fit neatly into a database.
Oncology moves quickly. Understanding what the literature means for the case in front of you takes more than another search.
OncoSkepsis brings clinical context, primary literature, and critical appraisal into one evidence workspace for Molecular Tumor Boards.
Meet the workspaceBuilt around the evidence
Every conclusion.
Open to examination.
Follow a statement back to its source. Read the reasoning. Make the judgement your own.
A considered path from case to board.
Start with the clinical question.
Tumour type, molecular findings, treatment history, and the question for the board. Evidence begins with context.
A structured case for evidence retrieval
Look beyond the first answer.
Retrieve primary literature and examine its relevance, strength, and limitations in the context of the case.
Sources with explicit evidence classifications
Make the reasoning reviewable.
Organise the findings into a citation-grounded evidence package. Keep the supporting sources close to the statements they inform.
An evidence package ready for the board
The final word belongs to your team.
Accept, reword, or reject the evidence. Record named reviewer decisions before the package is cleared for export.
A reviewed, traceable record of the discussion
Built for the people
around the table.
Different disciplines. One shared foundation for the discussion.
Evidence & pharmacy teams
Examine the literature, evidence strength, and treatment context together.
The review board
Accept, reword, or reject each statement. Keep a record of the judgement behind the output.
Trust is a process.
Build it into every case.
Traceable by design
Keep sources, appraisal, and reviewer decisions connected. An evidence package should show how it was reached.
Human review before export
Named reviewers accept, edit, or reject the evidence. Required reviews and checks must be completed before a package can be exported.
In your environment
Discuss an on-premise deployment with our team, shaped around your institution’s infrastructure and governance requirements.
Built on BioSkepsis.
Focused on oncology.
Literature retrieval, critical appraisal, and evidence synthesis, brought together around the clinical case.
For Molecular Tumor Boards
Give the next case
a clearer starting point.
We’re working with MTB design partners to shape how evidence reaches the board. Bring your perspective.
Contact usinfo@efevretech.com